Evidence map›Paper›PMID 26956978›Full record

ArticleForensic science, medicine, and pathology2016

Cardiac troponin T determination by a highly sensitive assay in postmortem serum and pericardial fluid.

Lucas González-Herrera, Aurora Valenzuela, Valentín Ramos, Antonia Blázquez, Enrique Villanueva

Abstract read
PubMed Publisher
In one paragraph

Article in Forensic science, medicine, and pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Cardiac-specific troponin-I (cTnI) in a post-mortem setting.International journal of legal medicine · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lucas González-HerreraDepartment of Forensic Medicine, Faculty of Medicine, University of Granada, Avenida de la Investigación 11, 18071, Granada, Spain. lgh@ugr.es.
Aurora ValenzuelaDepartment of Forensic Medicine, Faculty of Medicine, University of Granada, Avenida de la Investigación 11, 18071, Granada, Spain.
Valentín RamosForensic Pathology Service, Instituto de Medicina Legal, Ciudad de la Justicia, Fiscal Luís Portero García 6, 29010, Málaga, Spain.
Antonia BlázquezClinical Analysis Service, San Cecilio's Universitary Hospital, Avenida Doctor Olóriz 16, 18012, Granada, Spain.
Enrique VillanuevaDepartment of Forensic Medicine, Faculty of Medicine, University of Granada, Avenida de la Investigación 11, 18071, Granada, Spain.
Universidad de Granada · ESInstituto de Investigación Biosanitaria de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe main objective of this study was to test, for the first time, a highly sensitive cardiac troponin T (cTnThs) assay in postmortem serum and pericardial fluid and to evaluate cardiac troponin T (cTnT) levels and their stability after death at different postmortem intervals, in an attempt to determine the viability of the cTnThs assay in the postmortem diagnosis of the cause of death.

methodscTnT levels were determined in serum and pericardial fluid samples taken from 58 cadavers at known postmortem intervals, whose causes of death were categorized into the following groups: (1) sudden cardiac deaths, (2) multiple trauma, (3) mechanical asphyxia, and (4) other natural deaths. cTnT was determined by inmunoassay, using the Troponin T highly sensitive STAT assay (Roche(®)).

resultsAverage cTnT levels measured by a highly sensitive assay in postmortem serum were markedly higher than clinical serum levels. Moreover, similar results, higher cTnT levels in postmortem pericardial fluid, were obtained when compared to levels found in pericardial fluid taken from two living patients during coronary artery bypass surgery. cTnT levels in both postmortem fluids remained stable for up to 34 h after death. No differences in cTnT levels in either postmortem fluid by sex and age were detected. Levels of cTnT found in pericardial fluid in the other natural deaths group were significantly lower than the cTnT levels found in that postmortem fluid from any of the other causes of death groups.

conclusionIt is therefore reasonable to conclude that determination of cTnT by a highly sensitive assay in pericardial fluid can provide forensic pathologists with a complementary test to the diagnosis of cause of death.

Indexed as

Postmortem ChangesAdultAgedAged, 80 and overCadaverCause of DeathFemaleForensic PathologyHumansMaleMiddle AgedPericardial FluidTroponin TTroponin TCause of deathForensic pathologyHighly sensitive cardiac troponin T assayPostmortem biochemistry

Identifiers

PMID26956978
OpenAlexW2295216306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.